Einstein/Montefiore Department of Medicine

Department Faculty

Dr. Ladan Golestaneh, M.D.

Ladan Golestaneh, M.D.

Associate Professor, Department of Medicine (Nephrology)

Professional Interests

Dr. Ladan Golestaneh received an MD from New York Medical College in 1999 after obtaining a Master’s degree in Zoology at the University of Maryland and receiving fellowship awards to conduct basic science research at the NIH from 1993 to 1995. She completed internship and residency at Montefiore Medical Center in 2002 and a nephrology fellowship at Einstein in 2004.

Following fellowship, Dr. Golestaneh was hired as clinical instructor in the Einstein Division of Nephrology, where she set up the first critical care/ nephrology subspecialty Einstein/Montefiore and introduced continuous dialysis therapies at Montefiore. She was promoted to assistant professor in 2005 and associate professor status in 2012, and was elected to become medical director of the inpatient dialysis unit in 2005, medical director of Bedford Park Dialysis unit in 2008, and medical director of the home program at the Williamsbridge dialysis unit in 2014.

Dr. Golestaneh holds various administrative positions within the Division of Nephrology and Department of Medicine and is a steward for healthcare quality delivery. Her research interests include acute kidney injury (AKI) and the cardio-renal syndrome. She is principal investigator of several studies examining the role of renal resistive index and NGAL as predictors of AKI incidence in the ICU. She is also interested in the healthcare disparities that underlie prescribing habits and risk stratification models for acute kidney injury. She has examined antibiotics dosing with CRRT modalities and the role of minocycline as an agent to prevent post-cardiac-surgery AKI. Her recent research interests include care delivery models for end-stage renal disease patients, a project in which she collaborates with the Montefiore CMO.

Selected Publications

  1. Mokrzycki MH, Zhang M, Golestaneh L et al. “An Interventional controlled trial comparing 2 management models for the treatment of tunneled cuffed catheter bacteremia: a collaborative team model versus usual physician-managed care.” AJKD. 2006 Oct; 48(4):587-95.
  2. Fudge KG, Glicklich D, Pullman J, Golestaneh L. “Villous Adenoma in the native kidney of a renal transplant recipient”. Transplantation. 2006 Feb 27;81(4):638.
  3. Mokrzycki MH, Zhang M, Cohen H, Golestaneh L, Laut JM, Rosenberg SO. “Tunneled haemodialysis catheter bacteremia recurrence, infectious complications and mortality. Nephrol Dial Transplant. 2006 Apr;21(4):1024-31
  4. Golestaneh L, Laut J. Rosenberg S, Zhang M, Mokrzycki MH. Favourable outcomes in episode of Pseudomonas bacteremia when associated with tunneled cuffed catheters (TCCs) in chronic hemodialysis patients. Nephrol Dial Transplant. 2006 May; 21(5):1328-33.
  5. Golestaneh L, Melamed ML, Hostetter TH. Uremic memory: the role of acute kidney injury in long-term outcomes. Kidney Int. Oct;76(8):813-4, 2009.
  6. Golestaneh L. Bonding with a dialysis patient in the Bronx. Am J Med. Sep;122(9):884, 2009.
  7. Golestaneh L, Karam S, Lawrence J, Yang S, Greenberg M. Hypercoagulability in a patient with chronic chyluria, proteinuria and hypoalbuminaemia. Nephrol Dial Transplant. Oct;24(10):3240-3, 2009.
  8. Gardner C, Golestaneh L, Dhillon B, Shafer A. People Say There Are No Accidents: Poetry and Commentary. J Med Humanit. Jan 14, 2010.

Material in this section is provided by individual faculty members who are solely responsible for its accuracy and content.

Montefiore Medical Center
Medical Arts Pavilion
3400 Bainbridge Avenue
Bronx, NY 10467

Tel: 718.920.5442
Fax: 718.231.0293

Research Information